Hafnarfjordur, Iceland

Jon Valgeirsson

USPTO Granted Patents = 6 


Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Hafnarfjordur, IE (2011)
  • Hafnarfjorour, IN (2012)
  • Hafnarfjöröur, IS (2013)
  • Hafnarfjordur, IS (2012 - 2015)

Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jon Valgeirsson

Introduction

Jon Valgeirsson is a notable inventor based in Hafnarfjordur, Iceland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of quinoline-3-carboxamide derivatives. With a total of six patents to his name, Valgeirsson's work has had a considerable impact on the industry.

Latest Patents

Valgeirsson's latest patents include an improved, commercially viable, and industrially advantageous process for the preparation of quinoline-3-carboxamide derivatives. This process allows for the production of compounds such as laquinimod, or a pharmaceutically acceptable salt thereof, in high yield and purity. His innovative approach has the potential to enhance the efficiency of pharmaceutical manufacturing.

Career Highlights

Throughout his career, Jon Valgeirsson has worked with prominent companies in the pharmaceutical sector, including Actavis Group PTC EHF. His experience in these organizations has equipped him with the knowledge and skills necessary to drive innovation in drug development.

Collaborations

Valgeirsson has collaborated with several professionals in his field, including Nitin Sharadchandra Pradhan and Girish Dixit. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jon Valgeirsson's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…